{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Ocala",
      "address_1": "1210 SW 33rd Avenue",
      "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.",
      "address_2": "",
      "product_quantity": "32 units",
      "code_info": "Rx #'s:   0357871    0391634    0371936    0352518    0371936    0390747        0371936        0390747    0400018      0400326    0408192    0402171    0408101    0409503    0398622              0399780    0401796    0401796    0389109    0401003      0383611",
      "center_classification_date": "20120810",
      "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, West Indies",
      "state": "FL",
      "product_description": "MAGNESIUM CHLORIDE, PRESERVATIVE FREE 20% INJECTABLE\t100 ML  \t  \t1000 ML  \t500 ML  \t  \t  \t  \t  \t600 ML  \t  \t  \t  \t  \t  \t750 ML;  MAGNESIUM SULFATE  50% (500MG/ML) INJECTABLE\t14 ML  \t20 ML  \t4 ML;  \t  MAGNESIUM SULFATE IN 5% DEXTROSE 1% (1GM/100ML) INJECTABLE\t2400 ML;  \t  \t  \t  \t  \t  MAGNESIUM SULFATE IN 5% DEXTROSE 4% (2GM/50ML) INJECTABLE\t1200 ML;  MAGNESIUM SULFATE, P.F. 50% (500MG/ML) INJECTABLE\t180 ML  \t240 ML  \t4 ML  \t  \t  \t6 ML  (14 DIFFERENT PRODUCTS)",
      "report_date": "20120822",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab",
      "recall_number": "D-1568-2012",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "62443",
      "termination_date": "20140815",
      "more_code_info": "",
      "recall_initiation_date": "20120521",
      "postal_code": "34474-5138",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}